Tag: Andelyn Biosciences

Industry, Mergers and Acquisitions, Vaccines

Univercells and Andelyn Biosciences Form Separate Drug Development Partnerships

April 3, 2024

Via: Biopharm International

On Mar. 25, 2024 Univercells announced a collaboration with Altamira Therapeutics, a producer of nanoparticle-based technology, under which Univercells will use Altamira‚Äôs SemaPhore nanoparticle platform to deliver messenger RNA (mRNA) vaccines. Also on Mar. 25, Andelyn Biosciences, a contract development […]

Manufacturing, Research and Development

Andelyn Biosciences Opens New CGT Manufacturing Headquarters

June 22, 2023

Via: Biopharm International

On June 22, 2023, Andelyn Biosciences, a cell and gene therapy (CGT) contract development and manufacturing organization, announced the opening of its newly constructed manufacturing headquarters in Columbus, Ohio. According to a company press release, the 180,000-ft2 facility is intended […]

Cell and Gene Therapy, Industry, Mergers and Acquisitions

Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

February 1, 2023

Via: Contract Pharma

Andelyn Biosciences, a gene therapy contract development and manufacturing organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech focused on accelerating rare disease drug development, to manufacture a novel gene therapy (OT-004) to treat vision loss caused by […]